277 related articles for article (PubMed ID: 31578220)
1. NNAlign_MA; MHC Peptidome Deconvolution for Accurate MHC Binding Motif Characterization and Improved T-cell Epitope Predictions.
Alvarez B; Reynisson B; Barra C; Buus S; Ternette N; Connelley T; Andreatta M; Nielsen M
Mol Cell Proteomics; 2019 Dec; 18(12):2459-2477. PubMed ID: 31578220
[TBL] [Abstract][Full Text] [Related]
2. Improved Prediction of MHC II Antigen Presentation through Integration and Motif Deconvolution of Mass Spectrometry MHC Eluted Ligand Data.
Reynisson B; Barra C; Kaabinejadian S; Hildebrand WH; Peters B; Nielsen M
J Proteome Res; 2020 Jun; 19(6):2304-2315. PubMed ID: 32308001
[TBL] [Abstract][Full Text] [Related]
3. Determination of a Predictive Cleavage Motif for Eluted Major Histocompatibility Complex Class II Ligands.
Paul S; Karosiene E; Dhanda SK; Jurtz V; Edwards L; Nielsen M; Sette A; Peters B
Front Immunol; 2018; 9():1795. PubMed ID: 30127785
[TBL] [Abstract][Full Text] [Related]
4. Systematically benchmarking peptide-MHC binding predictors: From synthetic to naturally processed epitopes.
Zhao W; Sher X
PLoS Comput Biol; 2018 Nov; 14(11):e1006457. PubMed ID: 30408041
[TBL] [Abstract][Full Text] [Related]
5. Computational Tools for the Identification and Interpretation of Sequence Motifs in Immunopeptidomes.
Alvarez B; Barra C; Nielsen M; Andreatta M
Proteomics; 2018 Jun; 18(12):e1700252. PubMed ID: 29327813
[TBL] [Abstract][Full Text] [Related]
6. Accurate MHC Motif Deconvolution of Immunopeptidomics Data Reveals a Significant Contribution of DRB3, 4 and 5 to the Total DR Immunopeptidome.
Kaabinejadian S; Barra C; Alvarez B; Yari H; Hildebrand WH; Nielsen M
Front Immunol; 2022; 13():835454. PubMed ID: 35154160
[TBL] [Abstract][Full Text] [Related]
7. Integral Use of Immunopeptidomics and Immunoinformatics for the Characterization of Antigen Presentation and Rational Identification of BoLA-DR-Presented Peptides and Epitopes.
Fisch A; Reynisson B; Benedictus L; Nicastri A; Vasoya D; Morrison I; Buus S; Ferreira BR; Kinney Ferreira de Miranda Santos I; Ternette N; Connelley T; Nielsen M
J Immunol; 2021 May; 206(10):2489-2497. PubMed ID: 33789985
[TBL] [Abstract][Full Text] [Related]
8. NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data.
Reynisson B; Alvarez B; Paul S; Peters B; Nielsen M
Nucleic Acids Res; 2020 Jul; 48(W1):W449-W454. PubMed ID: 32406916
[TBL] [Abstract][Full Text] [Related]
9. Improved peptide-MHC class II interaction prediction through integration of eluted ligand and peptide affinity data.
Garde C; Ramarathinam SH; Jappe EC; Nielsen M; Kringelum JV; Trolle T; Purcell AW
Immunogenetics; 2019 Jul; 71(7):445-454. PubMed ID: 31183519
[TBL] [Abstract][Full Text] [Related]
10. Machine learning predictions of MHC-II specificities reveal alternative binding mode of class II epitopes.
Racle J; Guillaume P; Schmidt J; Michaux J; Larabi A; Lau K; Perez MAS; Croce G; Genolet R; Coukos G; Zoete V; Pojer F; Bassani-Sternberg M; Harari A; Gfeller D
Immunity; 2023 Jun; 56(6):1359-1375.e13. PubMed ID: 37023751
[TBL] [Abstract][Full Text] [Related]
11. NetMHCpan-3.0; improved prediction of binding to MHC class I molecules integrating information from multiple receptor and peptide length datasets.
Nielsen M; Andreatta M
Genome Med; 2016 Mar; 8(1):33. PubMed ID: 27029192
[TBL] [Abstract][Full Text] [Related]
12. How to Predict Binding Specificity and Ligands for New MHC-II Alleles with MixMHC2pred.
Racle J; Gfeller D
Methods Mol Biol; 2024; 2809():215-235. PubMed ID: 38907900
[TBL] [Abstract][Full Text] [Related]
13. Building MHC class II epitope predictor using machine learning approaches.
Eng LP; Tan TW; Tong JC
Methods Mol Biol; 2015; 1268():67-73. PubMed ID: 25555721
[TBL] [Abstract][Full Text] [Related]
14. Structural properties of MHC class II ligands, implications for the prediction of MHC class II epitopes.
Jørgensen KW; Buus S; Nielsen M
PLoS One; 2010 Dec; 5(12):e15877. PubMed ID: 21209859
[TBL] [Abstract][Full Text] [Related]
15. Benchmarking predictions of MHC class I restricted T cell epitopes in a comprehensively studied model system.
Paul S; Croft NP; Purcell AW; Tscharke DC; Sette A; Nielsen M; Peters B
PLoS Comput Biol; 2020 May; 16(5):e1007757. PubMed ID: 32453790
[TBL] [Abstract][Full Text] [Related]
16. RBM-MHC: A Semi-Supervised Machine-Learning Method for Sample-Specific Prediction of Antigen Presentation by HLA-I Alleles.
Bravi B; Tubiana J; Cocco S; Monasson R; Mora T; Walczak AM
Cell Syst; 2021 Feb; 12(2):195-202.e9. PubMed ID: 33338400
[TBL] [Abstract][Full Text] [Related]
17. Contemplating immunopeptidomes to better predict them.
Gfeller D; Liu Y; Racle J
Semin Immunol; 2023 Mar; 66():101708. PubMed ID: 36621290
[TBL] [Abstract][Full Text] [Related]
18. Predicted MHC peptide binding promiscuity explains MHC class I 'hotspots' of antigen presentation defined by mass spectrometry eluted ligand data.
Jappe EC; Kringelum J; Trolle T; Nielsen M
Immunology; 2018 Jul; 154(3):407-417. PubMed ID: 29446062
[TBL] [Abstract][Full Text] [Related]
19. Footprints of antigen processing boost MHC class II natural ligand predictions.
Barra C; Alvarez B; Paul S; Sette A; Peters B; Andreatta M; Buus S; Nielsen M
Genome Med; 2018 Nov; 10(1):84. PubMed ID: 30446001
[TBL] [Abstract][Full Text] [Related]
20. Robust prediction of HLA class II epitopes by deep motif deconvolution of immunopeptidomes.
Racle J; Michaux J; Rockinger GA; Arnaud M; Bobisse S; Chong C; Guillaume P; Coukos G; Harari A; Jandus C; Bassani-Sternberg M; Gfeller D
Nat Biotechnol; 2019 Nov; 37(11):1283-1286. PubMed ID: 31611696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
